Daratumumab has received a positive opinion from the European Medicines Agency, paving the way towards marketing approval for a treatment that has been shown to work in patients with multiple myeloma, an incurable blood cancer. ---Subscribe to MedNous to access this article--- Company News Regulation & Policy
